Further evidence of NAMPT’s significance in neuroendocrine malignancies comes from studies on small cell lung cancer (SCLC), revealing a strong reliance of cancer cells on NAD+ synthesis through the NAMPT-dependent salvage pathway. The gene discussed is NAMPT; the disease is cancer.